Overweight and obesity in children and adolescents

Neslihan Koyuncuoğlu Güngör1

  • 1Louisiana State University Health Sciences Center-Shreveport, Department of Pediatric Endocrinology, Shreveport, LA, USA. E-ma-il: ngungo@lsuhsc.edu.

Insights

Childhood obesity is a growing global health crisis, leading to early onset of serious health issues and high healthcare costs. Comprehensive management focusing on nutrition, exercise, and behavior is crucial due to limited medication options.

Area of Science:

  • Public Health
  • Pediatrics
  • Endocrinology

Background:

  • Childhood obesity has dramatically increased globally over the last 30 years.
  • This rise leads to early-onset obesity-related diseases affecting multiple organ systems.
  • Obesity significantly contributes to escalating healthcare expenditures.

Purpose of the Study:

  • To highlight the critical public health issue of childhood obesity.
  • To emphasize the need for early identification and intervention strategies.
  • To underscore the importance of comprehensive management programs.

Main Methods:

  • Review of current trends and consequences of childhood obesity.
  • Analysis of existing treatment limitations, particularly pharmacotherapy.
  • Discussion of essential components for a comprehensive management program.

Main Results:

  • Childhood obesity presents serious health risks including hypertension, dyslipidemia, and insulin resistance.
  • Current pharmacotherapy options for pediatric obesity are notably limited.
  • A multidisciplinary approach involving nutrition, exercise, and behavioral modification is essential.

Conclusions:

  • Preventing and treating childhood obesity is a critical public health priority.
  • Comprehensive management programs are vital due to limited pharmacologic options.
  • Physicians should advocate for obesity prevention and early treatment in community settings.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
361
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
319
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
2.0K
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K